Currency: AUD
Period
H1 FY2024 Earnings
--
<0.01
2.44M
Strong Buy
Apr 8, 2024
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Chimeric Therapeutics Ltd: Half Yearly Report and Accounts
Feb 28 16:19 ET
Chimeric Therapeutics Ltd: Annual Report to shareholders
Sep 28, 2023 03:54 ET
Chimeric Therapeutics Ltd: Appendix 4E and Preliminary Final Report
Aug 31, 2023 00:56 ET
Chimeric Therapeutics Ltd: Appendix 4D and Half Year Report
Feb 28, 2023 01:14 ET
Read more
Updated: Apr 8, 2024
Buy
Hold
Underperform
Sell
No Data